Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
06/2010
06/02/2010CN101209354B Medical blood-stopping healing agent for wound-surface and uses thereof
06/02/2010CN101199540B Polygonin sheet and preparing method thereof
06/02/2010CN101181288B Solid-state molecule disperse preparations of pennogenin series compounds
06/02/2010CN101167745B Small molecular sugar stable buffer used for blood platelet frozen-dried preservation
06/02/2010CN101120928B Vitamin K1 orally disintegrating tablets preparation and preparation method thereof
06/02/2010CN101104847B Vipera berus snake poison blood coagulation X factor activating enzyme and its extracting method and application
06/01/2010US7728037 Alpha-ketoglutarates of active ingredients and compositions containing same
06/01/2010US7727999 substituted 1,3,8-triaza-spiro[4.5]decan-2-one compounds, used as selective serotonin receptor antagonists, used rfor the treatment of schizophrenia, psychosis, headaches, hypertension, thrombosis, vasospasm, depression, anxiety, sleep disorders and appetite disorders
06/01/2010US7727982 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility
06/01/2010US7727981 monoamidino-containing compounds having good bioavailability and/or solubility, used as potent and specific inhibitors of blood coagulation in mammals, and as therapeutic agents for disease states characterized by coagulation disorders
06/01/2010US7727980 Tricyclic androgen receptor modulator compounds and methods
06/01/2010CA2426625C Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
06/01/2010CA2420055C Fibrinogen-lowering agent
06/01/2010CA2291851C Stabilized antithrombin iii preparation
05/2010
05/27/2010WO2010059401A2 Compounds that expand hematopoietic stem cells
05/27/2010WO2010059244A2 Method for reducing thrombocytopenia and thrombocytopenia-associated mortality
05/27/2010WO2010058846A1 4,6-diaminonicotinamide compound
05/27/2010WO2010058751A1 Pharmacologically acceptable salt of [1,3,4]oxadiazole compound or hydrate thereof
05/27/2010WO2010058669A1 Novel prostaglandin e1 derivative, and nanoparticle having same encapsulated therein
05/27/2010WO2010020423A3 Methods for treating bleeding disorders
05/27/2010WO2010005480A9 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
05/27/2010US20100130729 Mu-1, member of the cytokine receptor family
05/27/2010US20100130567 Medical agent for prevention or treatment of alzheimer 's disease
05/27/2010US20100130563 Inhibitors of plasma kallikrein
05/27/2010US20100130547 Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide
05/27/2010US20100130541 Processes for the preparation of clopidogrel
05/27/2010US20100130504 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
05/27/2010US20100130502 Compounds, Formulations, and Methods for Treating or Preventing Inflammatory Skin Disorders
05/27/2010US20100130447 Inhibitors of kinase activity
05/27/2010US20100130428 Polymer factor ix moiety conjugates
05/27/2010US20100130427 Polymer-factor viii moiety conjugates
05/27/2010US20100129372 Inhibition of pacap signalling for the prevention and treatment of thrombocytopenia
05/27/2010US20100129365 Treatment of inflammation using bst2 inhibitor
05/27/2010US20100129329 METHODS FOR USING ALDHbr CELLS TO SUPPLEMENT STEM CELL TRANSPLANTATION
05/27/2010US20100129320 Quinoline derivatives for modulating dna methylation
05/27/2010CA2740589A1 Compounds that expand hematopoietic stem cells
05/26/2010EP2189475A2 Fibroblast growth factor-like polypeptides
05/26/2010EP2189459A1 Stable crystalline salt of 5-methyll-(6S)-tetrahydrofolic acid
05/26/2010EP1781782B1 Modified vitamin k dependent polypeptides
05/26/2010EP1572168B1 Anti-infarction molecules
05/26/2010EP1424998B1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies
05/26/2010CN1935277B Preparation for the prophylaxis of restenosis
05/26/2010CN1835948B 2-acylaminothiazole derivative or its salt
05/26/2010CN1803184B Compound dragon's blood medicine
05/26/2010CN1736384B Mixture of higher primary aliphatic alcohols with acetylsalicylic acid and pharmaceutical formulation
05/26/2010CN1681811B Azolidinone-vinyl fused-benzene derivatives
05/26/2010CN1646138B Novel therapeutical use of agonist ligands specific to G2A receptor
05/26/2010CN1406245B Method of eliminating human serum albumin polymers
05/26/2010CN1359390B Factor VII a inhibitors
05/26/2010CN101712720A Human antibodies that bind human TNF alpha
05/26/2010CN101712676A Water soluble puerarin derivatives and preparation method and application thereof
05/26/2010CN101712659A Compound with platelet aggregation resisting activity and preparation method thereof
05/26/2010CN101712642A 5 site-sodium thiosulfate substituted elsinochrome derivative and preparation method and application thereof
05/26/2010CN101712489A Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same
05/26/2010CN101711876A Polyethylene glycol modified recombinant human granulocyte colony-stimulating factor and preparation method thereof
05/26/2010CN101711828A Decoction for promoting blood circulation
05/26/2010CN101711809A Medicine composition for treating postpartum melancholia, preparation method and application
05/26/2010CN101711799A Externally-applied powder used for midwifery of piglets
05/26/2010CN101711791A Method for preparing cat's-foot water extract and application thereof
05/26/2010CN101711771A Heparin derivative polysaccharide mixture and preparation method and medicinal composition thereof
05/26/2010CN101711770A Fomitopsis officinalis (Vill. : Fr.) Bond. polysaccharide particle preparation and preparation method thereof
05/26/2010CN101190895B N-[(3S)-1,2,3,4-tetrahydroisoquinolino-3-formacyl]amino acid, preparation method and application thereof
05/26/2010CN101081092B beverage for expelling toxin and treating melancholy
05/26/2010CN101049344B Pharmaceutical composition of Qishen in use for treating leucopenia, and preparation method
05/25/2010US7723503 nucleotide sequences or complements that encode polypeptides having omega-3 desaturase and delta-12 desaturase enzyme activity, used for making polyunsaturated fatty acids; additives for drugs, nutritional compositions, animal feeds, as well as other products such as cosmetics
05/25/2010US7723479 BSL3 polypeptides
05/25/2010US7723366 Cardiovascular disorders; antidiabetic agents; anticancer agents
05/25/2010US7723361 Kaposi's sarcoma; Crohn's disease; combination therapy with an epoxide hydrolase inhibitor
05/25/2010US7723344 Dipeptidyl peptidase inhibitors
05/25/2010US7723307 transglutaminase inhibitor; fibrosis, scarring, neurodegenerative diseases, autoimmune diseases, thrombosis, proliferative disorders, AIDS, psoriasis, inflammation; N-Benzyloxycarbonyl-L-phenylalanyl-6-dimethylsulfonium-5-oxo-L-norleucine; 6-diazo-5-oxo-L-norleucine reacted with N-protected amino acid
05/25/2010US7723304 Hypotensive agents; cardiovascular disorders; wound healing agents; antitumor agents; antidiabetic agents ; nephropathy; gastrointestinal disorders; alopecia; blood disorders ; urogenital disorders
05/25/2010CA2403423C Tri-aryl-substituted-ethane pde4 inhibitors
05/25/2010CA2269335C Platelet substitutes and conjugation methods suitable for their preparation
05/20/2010WO2010057142A2 Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti adhesion barriers and anti thrombotic materials
05/20/2010WO2010057036A2 Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof
05/20/2010WO2010056988A2 Methods of treating stroke using stem cell-like menstrual blood cells
05/20/2010WO2010056981A2 Methods and compositions for regulating iron homeostasis by modulation bmp-6
05/20/2010WO2010056765A2 Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents
05/20/2010WO2010056549A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/20/2010WO2010055119A2 Pharmaceutical composition comprising pimobendan
05/20/2010WO2010055023A1 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
05/20/2010WO2010055022A1 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
05/20/2010WO2010055021A1 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy
05/20/2010WO2010054503A1 Anticoagulant polypeptides and uses thereof
05/20/2010WO2010022017A3 Method and composition for enhancing hematopoietic stem cell mobilization
05/20/2010WO2009133204A3 Vector for use in medicine
05/20/2010US20100125052 Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents
05/20/2010US20100125049 Polymer factor viii moiety conjugates
05/20/2010US20100124569 Amnion derived adherent cells
05/20/2010US20100124536 Hemophilia Treatment by Inhalation of Coagulation Factors
05/20/2010CA2743639A1 Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof
05/20/2010CA2743496A1 Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents
05/20/2010CA2742871A1 Methods and compositions for regulating iron homeostasis by modulation bmp-6
05/20/2010CA2742297A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/20/2010CA2738885A1 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
05/20/2010CA2738884A1 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
05/20/2010CA2738883A1 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy
05/19/2010EP2186800A1 New mandelic acid derivatives and their use as thrombin inhibitors
05/19/2010EP2186792A1 2-(a-hydroxypentyl) benzoate and its preparation and use
05/19/2010EP2186524A1 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
1 ... 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 ... 671